dexelvucitabine has been researched along with Hepadnaviridae Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthillon, P; Cheng, YC; Germon, S; Guerhier, FL; Pichoud, C; Seigneres, B; Trepo, C; Zoulim, F | 1 |
| Chen, SH; Cheng, YC; Chevallier, M; Guerret, S; Hantz, O; Jamard, C; King, I; Le Guerhier, F; Li, XY; Pichoud, C; Trépo, C; Zoulim, F | 1 |
2 other study(ies) available for dexelvucitabine and Hepadnaviridae Infections
| Article | Year |
|---|---|
Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Topics: Animals; Disease Models, Animal; Ducks; Hepadnaviridae Infections; Hepatitis; Hepatitis B Virus, Duck; Hepatitis B Virus, Woodchuck; Hepatitis, Viral, Animal; Humans; In Vitro Techniques; Marmota; Reverse Transcriptase Inhibitors; RNA, Viral; Virus Replication; Zalcitabine | 2002 |
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model.
Topics: Animals; Antiviral Agents; DNA, Circular; DNA, Viral; Ducks; Hepadnaviridae Infections; Hepatitis B Virus, Duck; Liver; Reverse Transcriptase Inhibitors; Viral Proteins; Virus Replication; Zalcitabine | 2000 |